\u767c\u8868\u6587\u7ae0\uff1a<\/span><\/strong><\/p>2024<\/p>
- Le NTN, Han CL, Delila L, Nebie O, Chien HT, Wu YW, Bu\u00e9e L, Blum D*<\/sup>, Burnouf T*. <\/sup>Proteomics of Human Platelet Lysates and insights from animal studies on platelet proteins diffusion to hippocampus upon intranasal administration. APL Bioengineering<\/em>, 2024; doi: 10.1063\/5.0196553<\/li>
- Khalil A, Barras A, Boukherroub R, Tseng CL, Devos D, Burnouf T, Neuhaus W, Szunerits S. Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases [published online ahead of print, 2023 Oct 19]. Nanoscale <\/em>H<\/em>orizons<\/em>. 2024, 9<\/strong>, 14-43.<\/li><\/ol>
\u00a0<\/p>
2023<\/p>
- Burnouf T, Chou ML, Lundy DJ, Chuang EY, Tseng CL, Goubran H. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery. Journal of Biomedical Science<\/em>. 2023; 30(1): 79. Published 2023 Sep 14. doi:10.1186\/s12929-023-00972-w (IF: 11.0; CELL BIOLOGY in SCIE edition: 27\/191)<\/li>
- Chou ML, Babamale OA, Walker T, Cognasse F, Blum D,\u00a0Burnouf T*.\u00a0Blood-brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies.\u00a0Trends in Neurosciences\u00a0<\/em>(accepted). 2023; 46(9), 764\u2013779 (IF: 9; NEUROSCIENCES in SCIE edition: 7\/272)<\/li>
- Delila L, Nebie O, Le N-T-N , Barro L, Chou M-L, Wu Y-W, Watanabe N, Takahara M, Bu\u00e9e L, Blum D, Devos D, Burnouf T*. Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson’s disease and traumatic brain injury models. Bioengineering & Translational Medicine, <\/em>2023; 8(1): e10360. doi: 10.1002\/btm2.10360 (IF: 7.4 ; ENGINEERING, BIOMEDICAL in SCIE edition: 18\/96 )<\/li><\/ol>
\u00a0<\/p>
2022<\/p>
- Widyaningrum R, Wu YW, Delila L, Lee DY, Wang TJ*, Burnouf T*. In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration [published online ahead of print, 2022 Aug 10]. Platelets<\/em>. 2022; 33(8): 1237\u2013 doi:10.1080\/09537104.2022.2105829 (IF: 3.3 ; CELL BIOLOGY in SCIE edition: 123\/191 )<\/li>
- Burnouf T*, Walker T*. The multifaceted role of platelets in mediating brain function [published online ahead of print, 2022 May 24]. Blood<\/em>, 2022; 140(8): 815\u2013 doi:10.1182\/blood.2022015970 (IF: 20.3 ; HEMATOLOGY in SCIE edition: 3\/79 )<\/li>
- Nebie O, Bu\u00e9e L, Blum D*, Burnouf T*. Can the administration of platelet lysates to the brain help treat neurological disorders?. Cellular & Molecular Life Sciences<\/em>, 2022; 79(7): 379. Published 2022 Jun 24. doi:10.1007\/s00018-022-04397-w (IF: 8.0; CELL BIOLOGY in SCIE edition: 36\/191)<\/li>
- Burnouf T*, Goubran HA. Regenerative effect of expired platelet concentrates in human therapy: An update. Transfusion & Apheresis Science<\/em>, 2022; 61(1): doi:10.1016\/j.transci.2022.103363 (IF: 1.9 ; HEMATOLOGY in SCIE edition: 66\/79 )<\/li>
- Gouel F*, Timmerman K, Gosset P, Raoul C, Dutheil M, Jonneaux A, Gar\u00e7on G, Moreau C, Danel-Brunaud V, Duce J, Burnouf T, Devedjian JC, Devos Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis. Biomaterials<\/em>, 2022; 280: doi:10.1016\/j.biomaterials.2021.121311 (IF: 14.0 ; ENGINEERING, BIOMEDICAL in SCIE edition: 4\/96 )<\/li><\/ol>
\u00a0<\/p>
2021<\/p>
- Widyaningrum R, Burnouf T, Nebie O, Delila L, Wang TJ*. A purified human platelet pellet lysate rich in neurotrophic factors and antioxidants repairs and protects corneal endothelial cells from oxidative stress. Biomedicine & Pharmacotherapy<\/em>, 2021; 142: doi:10.1016\/j.biopha.2021.112046 (IF: 7.419; MEDICINE, RESEARCH & EXPERIMENTAL in SCIE edition: 30\/139)<\/li>
- Nyam-Erdene A, Nebie O, Delila L, Bu\u00e9e L, Devos D, Chou S-Y, Blum D, Burnouf T*. Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine. ACS Biomaterials Science & Engineering<\/em>, 2021; 7(12): 5823\u20135835. doi:10.1021\/acsbiomaterials.1c01226 (IF: 5.395; MATERIALS SCIENCE, BIOMATERIALS in SCIE edition: 18\/44)<\/li>
- Nebie O, Carvalho K, Barro L, Delila L, Faivre E, Renn TY, Chou ML, Wu YW, Nyam-Erdene A, Chou SY, Bu\u00e9e L, Hu CH, Peng CW, Devos D, Blum D, Burnouf T*. Human platelet lysate biotherapy for traumatic brain injury: pre-clinical assessment. Brain<\/em>, 2021; 144(10): 3142\u22123158. doi: 10.1093\/brain\/awab205 (IF: 15.255; CLINICAL NEUROLOGY in SCIE edition: 6\/212)<\/li>
- Nebie O, Barro L, Wu YW, Knutson F, Bu\u00e9e L, Devos D, Peng CW, Blum D*, Burnouf T*. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro<\/em>. Platelets, <\/em>2021; 32(2): 226\u2212237. doi: 1080\/09537104.2020.1732324 (IF: 4.236; CELL BIOLOGY in SCIE edition: 112\/194)<\/li>
- Johnson J, Wu Y-W, Blyth C, Lichtfuss G, Goubran H, Burnouf T*. Prospective Therapeutic Applications of Platelet Extracellular Vesicles. Trends in Biotechnology<\/em>, 2021; 39(6): 598\u2212 doi: 10.1016\/j.tibtech.2020.10.004 (IF: 21.942; BIOTECHNOLOGY & APPLIED MICROBIOLOGY in SCIE edition: 3\/158)<\/li>
- Delila L, Wu Y-W, Nebie O, Widyaningrum R, Chou M-L, Devos D, Burnouf T*. Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses. Platelets<\/em>, 2021; 32(2): 259\u2212 doi: 10.1080\/09537104.2020.1849603 (IF: 4.236; CELL BIOLOGY in SCIE edition: 112\/194)<\/li><\/ol>
\u00a0<\/p>
2020<\/p>
- Schallmoser K, Henschler R, Gabriel C, Koh MBC, Burnouf\u00a0 <\/sup>T*. Production and quality Requirements of human platelet lysate: A Position Statement from the working party on cellular therapies of the International Society of Blood Transfusion. Trends in Biotechnology,<\/em> 2020; 38(1): 13\u221223. doi: 10.1016\/j.tibtech.2019.06.002 (IF: 19.536; BIOTECHNOLOGY & APPLIED MICROBIOLOGY in SCIE edition: 3\/159)<\/li><\/ol>
\u00a0<\/p>
2019<\/p>
- Nebie O, Devos D, Vingtdeux V, Barro L, Devedjian JC, Jonneaux A, Chou ML, Bordet R, Bu\u00e9e L, Knutson F, Blum D*, Burnouf T*. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen\/UVA) platelet concentrates. Journal of Biomedical Science<\/em>, 2019; 26(1): doi:10.1186\/s12929-019-0579-9 (IF: 5.762; CELL BIOLOGY in SCIE edition: 47\/195)<\/li>
- Burnouf T*, Barro L, Nebie O, Wu Y-W, Goubran H, Knutson F, Segatchian J. Virus safety of human platelet lysate for cell therapy and regenerative medicine: moving forward, yes, but without forgetting the past. Transfusion and Apheresis Science<\/em>, 2019; 58(6): doi: 10.1016\/j.transci.2019.102674 (IF: 1.285; HEMATOLOGY in SCIE edition: 65\/76)<\/li>
- Burnouf T*, Agrahari V*, Agrahari V*. Extracellular vesicles as nanomedicines: hopes and hurdles in clinical translation. International Journal of Nanomedicine<\/em>, 2019; 14: 8847\u2212 doi: 10.2147\/IJN.S225453 (IF: 5.115; NANOSCIENCE & NANOTECHNOLOGY in SCIE edition: 33\/103)<\/li>
- Gouel F, Rolland A-S, Devedjian JC, Burnouf T, Devos D. Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates. Frontiers in Neurology<\/em>, 2019; 10: doi: 10.3389\/fneur.2019.00835. (IF: 2.889; CLINICAL NEUROLOGY in SCIE edition: 92\/204)<\/li>
- Agrahari V, Agrahari V, Burnouf PA, Chew CH, Burnouf T*. Extracellular Microvesicles as New Industrial Therapeutic Frontiers. Trends in Biotechnology<\/em>, 2019; 37(7): 707\u2212729. doi: 10.1016\/j.tibtech.2018.11.012 (IF: 14.343; BIOTECHNOLOGY & APPLIED MICROBIOLOGY in SCIE edition: 3\/156)<\/li>
- Henschler R, Gabriel C, Schallmoser K, Burnouf T, Koh M*. Human Platelet Lysate: Current Standards and Future Developments. Transfusion, <\/em>2019; 59(4): 1407\u22121413. doi: 10.1111\/trf.15174 (IF: 2.800; HEMATOLOGY in SCIE edition: 40\/76)<\/li><\/ol>
\u00a0<\/p>
2018<\/p>
- Harrison P, Alsousou J, Andia I, Burnouf T, Dohan-Ehrenfest D, Everts P, Langer H, Magalon J, Marck R, Gresle P. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis<\/em>, 2018; 16(9): 1895\u2212 doi: 10.1111\/jth.14223 (IF: 4.662; HEMATOLOGY in SCIE edition: 17\/73)<\/li><\/ol>
\u00a0<\/p>
2017<\/p>
- Gouel F, Do Van B, Chou ML, Jonneaux A, Moreau C, Bordet R, Burnouf T, Devedjian JC, Devos D* The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways. Journal of Tissue Engineering and Regenerative Medicine<\/em>, 2017; 11(11): 3236\u2212 doi: 10.1002\/term.2222 (IF: 4.089; CELL BIOLOGY in SCIE edition: 69\/190)<\/li>
- Chou ML, Wu JW, Gouel F, Jonneaux A, Timmerman K, Renn TY, Laloux C, Chang HM, Lin LT, Devedjian JC, Devos D*, Burnouf T*. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson’s disease. Biomaterials<\/em>, 2017; 142: 77\u221289. doi: 10.1016\/j.biomaterials.2017.07.018 (IF: 8.806; ENGINEERING, BIOMEDICAL in SCIE edition: 1\/78)<\/li>
- Chou ML, Burnouf T*. Current methods to manufacture human platelet lysates (HPLs) for cell therapy and tissue engineering: possible trends in product safety and standardization. Vox Sanguinis, <\/em>2017; 12(1): 168\u2013175. doi:10.1111\/voxs.12316 (IF: 2.107; HEMATOLOGY in SCIE edition: 46\/71)<\/li><\/ol>
\u00a0<\/p>
2012<\/p>
- Burnouf T*, Kuo YP, Blum D, Burnouf S, Su CY*. Human platelet concentrates: a source of solvent-detergent treated highly enriched brain-derived neurotrophic factor (BDNF). Transfusion<\/em> 2012;52:1721-1728.<\/li><\/ol>
\u00a0<\/p>
\u00a0<\/p><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t